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EDITORIAL 
Research Tourism, Indian Psychiatry and 
International Databases 
Recently, the Drugs Controller General of 
India (DCGI) has written to several 
organizations seeking information on their 
infrastructure for drug trials. The DCGI was 
actually trying to figure out the Good Clinical 
Practice (GCP) training requirements at the 
national level. The DCGI wishes to build up 
a pool of GCP trained clinicians in the 
country by initiating a series of training 
campaigns. The first residential workshop 
"GCP Theory and Practice" is scheduled to be 
held in Madh Islands, Mumbai (February 13-
15, 2003). It is gratifying to see that the 
workshop would include nearly everything 
that is connected with GCP: GCP 
fundamentals, Ethical issues in clinical research, 
GCP compliant SOPs, Investigators' 
responsibilities, Site monitoring, Quality 
control and audit, Adverse event management, 
data management and Clinical research 
organizations (CROs). The Central Drugs 
Standard Control Organization (CDSCO) is 
now actively pursuing the goal of improving 
the environment for clinical trial in the 
country with help from the WHO-India 
Country Office. 
On one hand, this indicates the nature and 
extent of requests the DCGI has been receiving, 
for GCP trials, from the international Pharma 
majors. On the other, it may be read as an 
attempt to respond to an emerging trend of 
research partnership in global health campaign. 
This is an extremely valid concern for the 
time has now come to realize that there is 
a palpable shift from earlier cynicism about 
psychiatric research in developing societies 
towards appreciating the relative merits and 
potential rewards of conducting research in 
partnership in a developing economy. 
One would be tempted to comment that 
there was nothing new about doing research 
in collaboration, as the latter was never a 
dirt)- word. However, when it comes to the 
developing world, one notes that a good 
number of researches that are undertaken here 
would probably not be printed in journals 
having reasonably good impact factor (Patcl & 
Sumathipala, 2001). It has been claimed that 
psychiatric researches in developing countries 
lack focus on major psychiatric problems. It is 
further argued these researches are donor-driven, 
not priority-driven. It is also alleged that there 
are problems in documentation and quality. 
Some of these arguments are partly correct. 
The research environment is far from being 
conducive for several researchers. There is 
inadequate felt need for conducting research. 
Attitudinal deficits plague mental health 
research, translating into hostility and ridicule. 
Poor resource allocation, though a problem, 
is a somewhat weaker argument. There is a 
glaring problem of poor resource utilization 
as well. 
However, much of these are probably 
changing. Increasingly, there is a felt need to 
pursue and respect research carried out in the 
developing or poor income countries. Even in 
the context of simple drug trials, the major 
international pharmaceutical companies now 
recognize that India is a viable destination for 
research tourism. It offered a sound 
opportunity for carrying out clinical trials. 
There is a large patient pool, good number 
of well-trained and well-meaning investigators 
whose expertise can match those anywhere in 
the world. The international quality managers 
and auditors have a substantial presence in 
India and there are a number of premier 
institutions that can shoulder the responsibility 
of a GCP trial and stand scrutiny of the 
auditors from international regulatory agencies, 
such as the FDA. All this can happen at a 
considerably low cost as compared to the 
developed or high-income countries. Already, 
about 8 centres carried out the ziprasidonc 
trial for Pfizer. Burrows Welcome sponsored 
their lamotriginc study through Quintilcs-
Spcctral India operations. AstraZeneca also 
recruited several centres through the Quintiles 
for several studies involving quetiapine in 
manic disorder. Janssen-Cilag has presumably 
finished their study of risperidone in mania in 
centres. One notes that most of these are 
multicentre trials primarily for satisfying the 
regulatory authorities abroad. All the Pharma 
companies are coming back with more 
protocols! 
In other context too, there is a palpable 
shift of interest in favour of research conducted 
in developing nations. Many psychiatrists in 
these countries have embarked on joint 
collaborative studies with their western 
counterparts, with or without funding support. 
Here again, there is the realization that a large 
number of treated as well as untreated patients 
are available. Through their interactions and 
formal meetings in international conferences, 
both sides understand the need to collaborate 
with one another in search for the answers 
to interesting questions of immense clinical 
relevance. As a result, psychiatric research is 
fast achieving a global relevance. 
For instance, Kumar et al (2003) in this 
issue, observe that ECI" works for treatment 
resistant schizophrenia but raise an important 
question: arc there lasting benefits with ECT? 
Does one require administering maintenance 
ECTs to those who benefited from an acute 
course of, say 12 to 15 ECTs! These questions 
could be answered anywhere in the world 
theoretically. However, Chanpattana in 
Thailand chose to conduct the study in 
collaboration with Sackcim in the USA and 
came up with brilliant answers (Chanpattana 
et al., 1999). In this very issue, a similar 
reference is made of the New Delhi -
Newcastle collaborative project on bipolar 
disorders wherein the effect of mood stabilizers 
on neurocognitive functions could be worked 
out (Moore & Gallagher, 2003). 
There is a possibility that a few researchers 
in a developing country such as India may at 
rimes feel somewhat demoralized because he > 
has to operate with very little incentive to 
conduct his research. This gets further 
aggravated, if and when he finds it difficult 
to have the paper(s) accepted by a decent, 
indexed international journal! Consequently, 
a Mathew effect sets in wherein more and 
more investigations from the developing world, 
conducted with gr; nt difficulty and numerous 
odds, cannot be published in leading journals, 
depriving him of the due appreciation for his 
work. 
It is imperative to note that there is no 
dearth of quality research in India in the field 
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of psychiatry. At present, however, there is a 
general tendency to send a quality report to 
other, international journals. Many are rejected, 
and research is not published in time losing out 
on topicality This could be depressing for many 
and justifiably so. Why is the 1JP not indexed, 
then? The question is relevant. As and when this 
journal is indexed, first time quality submissions 
would pour in, triggering a chain of positive 
events with incremental effects in terms of 
quality. 
After all, a journal is the creation of the 
authors and readers. F.vcryonc is apparently 
convinced that indexing of I|P in international 
databases such as Index Medicus has to be a 
top priority. Therefore, the authors and readers 
have to make efforts to uplift the quality, as 
quality alone is the deciding factor. 
Hence, it is important that we deal with 
the issues and processes of indexing the journal 
in Index Medicus. Here is a glimpse of what 
goes on, (modified from hup:// 
www.nlm.nih.gov/pubs/factshcets/ 
j_sel_faq.html) 
The decision whether or not to index a 
journal is made by the Director of the 
National Library of Medicine, based on 
considerations ol both scientific policy and 
scientific quality. The Literature Selection 
Technical Review Committee (I.STRC) 
arranges to review |ournal titles and assess the 
quality of their contents. 
Approximately 4,S(H! journals are currently 
indexed and included in the MUDI.1NE 
database. There are about 3,630 titles in Index 
Mtilicns. The I.STRC. would usually meet 
three times a year to consider approximately 
14(1 titles at each meeting. 
The users of the MHDLARS indexes are 
researchers, health care practitioners, educators, 
administrators, and students. It is not difficult 
to see that their needs would vary considerably. 
It is thus very important that the indexes do 
not concentrate on one set of users at the 
expense of another. Trie content, form and 
accepted structure of the journals vary greatly. 
National Library of Medicine favours a 
practical system for selection of journals that 
will reflect these different needs. The selection 
depends greatly on the judgment of 1.STRC 
members and the Director. However, the 
following are the critical elements that serve 
as a genera] guide: 
Firstly, the scope and coverage is important 
in that the journal under review should 
publish papers mainly on core biomedical 
subjects. Psychiatry and behavioural sciences 
are regarded as a core area. 
The main deciding factor in selecting a 
journal for indexing is its scientific merit. The 
Committee members look at validity, 
importance, originality, and contribution to 
the coverage of the field. These key factors 
are considered before recommending a journal 
for indexing. 
Quality of editorial work is one of the 
major concerns, too. The contents of the 
journal must have all those features that 
contribute to the objectivity, credibility, and 
quality, including information about the 
processes of selecting articles, with special 
reference to external peer review. It should 
have statements concerning ethical guidelines, 
disclosure of financial conflicts of interest, 
timely corrigendum, explicit responsible 
retractions and a forum for airing comments 
and dissenting opinion. Nothing should raise 
questions about the objectivity of the published 
material. Sponsorship by national or 
international professional societies may be 
considered. The Indian Psychiatric Society 
sponsors the IJP. 
The quality of the production is assessed 
as well, because the get-up, layout, printing, 
graphics and illustrations are all important 
aspects of a journal. Ifte National Library of 
Medicine prefers that journals of archival 
importance be printed on acid-free paper. 
This is not a requirement for selection, though. 
The MEDLINE and Index Medicus are 
facilities that cater to mainly those in the 
health professions: researchers, practitioners, 
educators, administrators, and students. The 
phrase health professionals includes physicians, 
nurses, dentists, veterinarians, and the many 
types of allied health professionals in the 
research and health care delivery systems. 
According to the type of papers the journals 
are sub-typed. Many types are indexed. One 
would note that publications that consist primarily 
of reprinted articles, reports of association 
activities, abstracts of the literature, news items 
or book reviews, are not usually indexed. The 
IJP may be regarded as a journal that publishes 
original research reports. 
In the recent years, the members of Indian 
Psychiatric Society would have very often 
discussed about the aforementioned details 
governing the process of indexing in Index 
Medicus. The preoccupation with a place in 
international database is understandable and 
widely shared. For instance, the President of 
the World Journal of Biological Psychiatry, 
Professor Carlos Roberto Hojaij writes, in his 
letter to the readership, in December 2002, 
"Although that achievement (indexing of the 
journal by Index Medicus^ may represent just 
another bureaucratic step in its successful 
evolution, considering the short period of time 
to get that recognition (middle of the third 
volume), it really represents the outstanding 
quality, and worldwide acceptance of the World 
journal of Biological Psychiatry." 
Now, it is in the hands of all the members 
of the Society and the authors of IJP to 
strengthen the quality of the IJP. After all, 
a journal is the creation of its authors and 
readership. 
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